Top Markets
#1 MowCat MowCat +48.65%
#2 Bitway Bitway +30.15%
#3 Velvet Velvet +24.66%
#4 Fake World Assets Fake World Assets +21.42%
#5 aPriori aPriori +20.54%
#6 OVERTAKE OVERTAKE +18.66%
#7 Biconomy Biconomy +15.83%
#8 Zerebro Zerebro +14.34%
#9 Derive Derive +12.47%
#10 Perle Perle +11.32%
Coin of the day
MowCat MowCat
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Ultimovacs ASA Ultimovacs ASA

Ultimovacs ASA

ULTI
Rang in Aktien #34179
Ultimovacs ASA is a pharmaceutical company based in Oslo, Norway, established... Ultimovacs ASA is a pharmaceutical company based in Oslo, Norway, established in 2011. The firm specializes in developing immunotherapies to combat various cancers. Its main product in development is UV1, a peptide vaccine engineered to stimulate a T-cell immune response against telomerase, an antigen found widely across different cancer types.
Aktienkurs
$0.17687105
Zuletzt synchronisiert: 2025-04-01
Marktkapitalisierung
$6.08M
Veränderung (1 Tag)
-89.96%
Veränderung (1 Jahr)
0.00%
Land
NO
Handel Ultimovacs ASA (ULTI)

Kategorie

Healthcare
Kursverlauf für Ultimovacs ASA (ULTI)
Höchster Schlusskurs: $0.18 am 2025-04-01

Niedrigster Schlusskurs: $3.63 am 2019-06-01
Kursverlauf der Aktie von Ultimovacs ASA von 2019 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2025 -16.73%
2024 -98.08%
2023 -4.48%
2022 -2.52%
2021 47.73%
2020 105.54%
2019 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE